ArticleCancers2026

Spatial Immune Profiling and AI-Based Classifiers Identify Predictors of BCG Therapy Outcomes in High-Risk Non-Muscle-Invasive Bladder Cancer.

Melinda Lillesand et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.